Exponent, Inc. (EXPO)
NASDAQIndustrialsEngineering & ConstructionSnapshot 2026-10-29
NASDAQIndustrialsEngineering & ConstructionSnapshot 2026-10-29
Research Workspace
Put EXPO beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Industrials is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Operating margin near 27%: Direct metric needs a verified mapping.
View ThesisManagement screens strong on capital allocation, earnings delivery, market reaction to earnings.
View ManagementExpectations look high — what the market is pricing in runs ahead of what analysts forecast.
View ValuationThis stock is volatile — it swings about 1% on a typical day and fell roughly 32% in its worst 12-month stretch.
View RiskEXPO depends on specialized consulting sustaining revenue growth and strong EBITDA margins despite an elevated valuation. Revenue growth was 14% year over year in Q1, 21% in Q2, then 18% in Q3. Q3 GAAP EPS beat consensus by 6.7%, and the company raised its 2026 growth outlook. EXPO trades at 35× P/E versus a 23× peer median and 31× its history. Expectations look full because the market prices in more growth than our forecast. The risk is premium compression, especially with elevated execution concerns and a 26% next-quarter miss probability. Peer multiples imply a price about 63% below where it trades; the thesis is on watch, and this read is provisional.
Trailing returns as of 2026-10-30. EXPO is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 4 analysts currently covering EXPO (as of Oct 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare EXPO with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| EXPO Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Research & Consulting Services — fair value, gap to price, and forward P/E.
Compare the value case
Put EXPO next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Maintain revenue growth and strong EBITDA margins
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Raised 2026 growth and EBITDA margin outlook directly support revenue growth and profitability.

Advances: Drive revenue growth in specialized consulting services
Strong growth and an EPS beat support revenue momentum, though the headline alone gives limited detail.

Advances: Invest in talent and leadership to support growth
Investment in talent supports growth objectives.

Leadership change may impact operational strategy.